本頁面由Tiger Trade Technology Pte. Ltd.提供服務

HCW Biologics Inc.

2.24
-0.1900-7.82%
盤後2.20-0.0400-1.79%19:58 EDT
成交量:9.41萬
成交額:21.68萬
市值:411.33萬
市盈率:-0.08
高:2.45
開:2.43
低:2.16
收:2.43
52周最高:36.65
52周最低:1.50
股本:183.63萬
流通股本:164.98萬
量比:0.14
換手率:5.71%
股息:- -
股息率:- -
每股收益(TTM):-27.1846
每股收益(LYR):-63.7804
淨資產收益率:-151.36%
總資產收益率:-13.88%
市淨率:0.55
市盈率(LYR):-0.04

資料載入中...

2026/05/14

重要事件披露

Form 8-K - Current report
2026/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/24

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/04/23

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/04/17

重要事件披露

Form 8-K - Current report
2026/03/31

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/31

重要事件披露

Form 8-K - Current report
2026/03/17

重要事件披露

Form 8-K - Current report
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/19

重要事件披露

Form 8-K - Current report
2026/02/17

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/13

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/13

重要事件披露

Form 8-K - Current report
2026/02/12

SEC問詢函

Form CORRESP - Correspondence
2026/02/12

SEC問詢函

Form CORRESP - Correspondence
2026/02/11

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/01/28

SEC問詢函

Form CORRESP - Correspondence
2026/01/09

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933